Vascular anomalies are congenital lesions that usually occur sporadically, but can be inherited. Previously, we have described that venous malformations, localized bluish-purple skin lesions, are caused by an activating mutation in the TIE2/TEK receptor. Moreover, we mapped another locus to chromosome 1p21-p22, for venous malformations with glomus cells (VM-GLOM). Here we report a physical map, based on 18 overlapping YAC clones, spanning this 5-Mb VMGLOM locus, from marker GATA63C06 to D1S2664. In addition, we report a sequence-ready PAC map of 46 clones covering 1.48 Mb within the YAC contig, a region to which we have restricted VMGLOM. We describe 21 new STSs and nine novel CA repeats, seven of which are polymorphic. These data will enable positional cloning of genes for diseases mapped to this locus, including the VMGLOM gene, likely a currently unknown regulator of vasculogenesis and/or angio-
Venous malformations (VMs) are bluish-purple vascular lesions that can be single or multiple (16) . They are most often localized on the skin and mucous membranes. In a family in which these lesions are inherited as an autosomal dominant trait, we identified a locus (VMCM1) on chromosome 9p21 that is linked to the phenotype (4) . We found that the mutation in this locus is in the gene encoding the endothelial-specific receptor tyrosine kinase TIE2/TEK. The R849W mutation in the intracellular kinase domain leads to hyperactivation of the receptor in a ligand-independent manner (15) . Another amino acid substitution, Y897S, identified in a separate family, seems to have a similar effect (5) .
Since not all families with inherited venous malformations showed linkage to the TIE2/TEK gene, we used random linkage mapping to identify another locus on chromosome 1p21-p22 (3) . Because of the presence of undifferentiated smooth muscle cells ("glomus" cells) in histologic slides of these venous malformations, we named this locus VMGLOM. The pathognomonic histologic finding suggests that, like TIE2/TEK, the VM-GLOM gene regulates the development of smooth muscle layering in veins and thereby angiogenesis.
To identify the VMGLOM gene, we initiated positional cloning by creating a YAC-based physical map on the basis of information from the Whitehead database (17) . We selected 18 overlapping YAC clones that cover the 5-Mb area between the polymorphic markers AFMa205Xd5 and D1S2775 that define the VMGLOM locus (3). The integrity of the clones was checked by amplifying markers 24 to 49 from the contig WC1.14 (17; Figs. 1A and 1B). These clones were used for the precise localization of additional STSs selected from various databanks (Figs. 1B and 1C) and created from our end-of-clone sequences (Table 1) . We also identified the position of three polymorphic markers (D1S188, D1S406, and D1S1170) known to localize to this region (1) . In contrast to Allikmets et al. (1), we were not able to localize marker WI-7719 to our YAC map, and the order for markers D1S2849 to D1S286, as well as for D1S424 and D1S406, was inverted (Fig. 1) . These results were later confirmed with our PAC map (Fig. 2) . Based on the known sizes of the YAC clones, we estimate the size of the VMGLOM locus to be 5 Mb.
Having previously excluded three known genes as disease-causing in VMGLOM (3), we needed to identify new positional candidate genes. Thus, we selected more than 80 STSs from several databases on the basis of their localization to the vicinity of the VMGLOM locus (6, 12-14). Every marker was amplified by PCR on six overlapping YACs covering the whole region (736E1, 751F11, 946C5, 957D9, 944B12, and 759D7; Fig. 1A) , with genomic DNA as positive control. Fortyeight positive markers were identified (a complete list of tested STSs is available via http://www.icp.ucl.ac.be/ vikkula). Finer localization of these 48 markers was performed by testing all the YAC clones in the vicinity of the positive one(s). Using this strategy, 5 markers, WI-13478, D1S2779, G32495FS, G31522, and WI-15861, were precisely localized between existing markers of the YAC map (Fig. 1B) , whereas the 43 other STSs were only roughly localized (Fig. 1C) . A Blast homology search (2) was performed for each marker, and several genes were retrieved: acidic cal-
ponin (CNN3), breast cancer anti-estrogen resistance 3 (BCAR3), Evi-5 homologue (EVI5), peroxisomal 70-kDa membrane protein (PXMP1), PTPL1-associated RhoGAP (PARG1), and KIAA0231 (Figs. 1B and 1C).
Concurrently with these studies, we identified haplotype sharing in VMGLOM among 12 families, resulting in the reduction of the candidate region from AFMa205Xd5-D1S2775 to D1S1170 -D1S2849 (9) . Based on the size of the YAC 957D9, containing the whole region showing haplotype sharing, the VM-GLOM locus should be less than 1.48 Mb (Fig. 1) . Thus, we undertook the creation of a more precise physical map of this area (Fig. 2) . In the Sanger Centre database (12), we found 20 PAC clones containing STSs of the VMGLOM haplotype-shared area. Each clone was 
FIG. 2. Schematic representation of PAC-based STS and transcript map of VMGLOM.
Gene names, boldface italics, underlined; polymorphic markers, boldface type; novel CA repeats, boldface italics; markers with unknown order, gray boxes. Fingerprinted PAC clones, boldface type; underlined clones were selected for sequencing (12) . X, positive PCR result;
Ϫ, negative PCR result; R, new end-of-clone STS. Best annealing temperature for PCR is given for each STS.
tested by PCR for all the markers localized between D1S1170 and D1S2779 (Fig. 1) . A manual analysis of the results allowed clustering of the PACs in four contigs. With a second search in the Sanger Centre database, we picked 23 additional PACs. None closed the gaps between the PAC clusters.
To join the different PAC islands, we generated 21 new STSs by sequencing the ends of the protruding PAC clones (identified as T7 or SP6; Table 1 ). Marker 33SP6, from the centromeric end of clone 775d17, closed the first gap (Fig. 2) . Similarly, marker 21SP6 enabled us to bridge clone 981e3 with clone 606m5. However, the novel markers 47SP6 and 17T7 inside the last gap did not reach any clone from the other cluster (Fig. 2) . Thus, a screening of the Human RPCI-1 PAC Library filters (7, 8) , using the amplified 17T7 as a probe, was performed. This resulted in the identification of two new PACs, 104o6 and 226k2, which bridged the two contigs (Fig. 2) . To obtain double coverage for the single-linked point in the map around marker 21SP6, additional new clones were screened from the PAC library with 21SP6. Clone 103d10, which overlaps clones 606m5 and 981e3, was identified. This overlap was confirmed with the novel STS 69SP6 (Fig. 2) .
To identify new polymorphic markers, nine PAC clones were selected for CA-repeat screening. Seven of these were not positive for a known CA repeat and two contained one CA repeat (Fig. 2) . These PACs were subcloned, and the libraries were screened by hybridization with a radiolabeled (GT)16 probe. More than 40 positive subclones were sequenced. This enabled us to GAG GTC AGG AGT TCG AGA C GTA GGA GTG CAT CAC CAT GC 139 PCR Not specific PCR Not specific  -33CA1  775d17  TCT GAC TTT GAC GTT GTA ACC  CAG TCA CTT CTC TTT CAT CAG  157  55  12/16  7  50CA1  617o13  TGT AAA GAG CTG CTG CAC TC  AGC AAA GTG ACA TCT GAC TTC  129  64  15/16  6  56CA1   b   612c19  CTT GAA GCC AGG AGT TTG AG  CAG CCT CCC AAG TAG CTA G  141  55  0/16  1  56CA2  612c19  ATG TTG TTC AGC GCA ACC TC  AGC CTG GAT GAC AGA ATG AG  181  55  7/16  4  56CA3  612c19  GGT ATG GTG AAT GAA GCA TTC  TGA GCT CCT GAA TTA CAC ATC  148  58  6/16  2  69CA1  103d10  TTT TTA AAT CCC ATA ACT TGC C  GCA GTG GTG AGA GAG TGG  175  58  11/16  6  75CA1  226k2  CAA CAG GTT GAG AAG GCA AG  GGG TGA CAG AGT GAG ACT G  169  58  11/16  5  75CA2  226k2  CAA CAT AGA TCC TGG GAA CG  GAG AAT CTG ACC TTG AAG GC  195  58  10/16  5 a Specific on the PAC but not on genomic DNA. b Not polymorphic.
identify nine different CA repeats ( Table 2) . The sublibrary from clone 828k3 did not show any clone containing a putative repeat, and the eight CA repeats identified from clone 981e3 revealed only the known D1S2776. Three of 12 subclones from PAC 612c19 were identical to D1S2779. The nine novel markers were tested by PCR for their specificity on genomic DNA. All except 25CA1 gave a unique signal. Genotyping of 16 unrelated control individuals for the eight specific STSs showed that seven of them were polymorphic (Table 2) . To integrate additional published information into our PAC map, 10 recently reported markers (10) were localized (Fig. 2) . We noted that 2 of them, D1S2868 and D1S1870E, had an inverted localization. The whole map is now covered by 46 clones and 69 STSs, 4 of which correspond to known genes: Ribosomal protein L5 (RPL5), KIAA0231, EVI5 (10) , and GFI1, a growth factor independence gene (11) . In addition, STSs G4415, D1S1887E, G35002, GDB:191074, G29243, and WI-20561 represent 4 putative genes as they correspond to an uncharacterized cDNA or to an EST cluster (14). On average, the VMGLOM area should correspond to roughly 47 genes. However, as the gene encoding EVI5 was shown to cover 270 -300 kb (10) (around NB4S-UTR3 and G25867; Fig. 2) , and the gene GFI1 covers 50 kb (11), less than 30 genes would be expected to reside in the remaining maximum of 1.1 Mb. In addition, as 1p21-p22 is considered a low-density gene area on the basis of the number of EST hits (6), the number of genes should be even lower. Thus the tags we have for 8 genes may represent the majority of the genes in the area. Only 3 of these, GFI1, EVI5, and RPL5, localize to the minimal VMGLOM locus and represent positional candidates for venous malformations with glomus cells (Fig. 2) . EVI5 is involved in a translocation breakpoint in stage 4S of neuroblastoma that creates the NB4S fusion gene between EVI5 and the TRNG10 gene from chromosome 10q21 (10) , and GFI1 and RPL5 do not seem obvious candidates. Thus, we may still lack a tag for the VMGLOM gene.
To sequence and identify genes in the area covered by the PAC map, one should select clones presenting a minimum of overlap. Seven of the 46 clones have already been selected for sequencing (Fig. 2 and Ref. (12) ). To cover the whole region, clones 775d17, 1090k7 or 737e21, 606m5, 103d10, 615c19, 1091c4, and 226k2 should also be selected. Fingerprinting of these 15 clones by HindIII restriction digestion confirmed the overlaps (data not shown). To date, clone 976o13 is completely sequenced, and clones 621b10 and 1014c4 are unfinished (12) . No additional gene can be retrieved with these sequences by Blast.
In summary, we report a 5-Mb YAC map and a PAC map of maximally 1.48 Mb of chromosome 1p21-p22, with a high density of STS markers. This gives the necessary tools for sequencing this part of the human genome and for the identification of genes in this locus. In addition, we report seven novel, highly polymorphic dinucleotide repeat markers, which will be useful for linkage, haplotypic, and association analyses involving this chromosomal area. We conclude that these data will enable the identification of the gene responsible for venous malformations with glomus cells, likely a novel gene important for vascular development.
